IQVIA Holdings (IQV) Beats Q4 Earnings and Revenue Estimates

Core Insights - IQVIA Holdings reported quarterly earnings of $3.12 per share, exceeding the Zacks Consensus Estimate of $3.10 per share, and up from $2.84 per share a year ago, indicating a 9.86% year-over-year increase [1] - The company achieved revenues of $3.96 billion for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 0.89% and showing a year-over-year increase from $3.87 billion [2] - IQVIA has consistently outperformed consensus EPS and revenue estimates over the last four quarters, indicating strong operational performance [2] Earnings Outlook - The sustainability of IQVIA's stock price movement will largely depend on management's commentary during the earnings call and future earnings expectations [3][4] - Current consensus EPS estimate for the upcoming quarter is $2.59 on revenues of $3.85 billion, while for the current fiscal year, the estimate is $11.80 on revenues of $16.02 billion [7] Industry Context - The Medical - Instruments industry, to which IQVIA belongs, is currently ranked in the top 34% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]